Latest peripheral artery disease Stories
OhioHealth Riverside Methodist Hospital is nation's first to use recently-approved drug-coated stent COLUMBUS, Ohio, Feb. 28, 2013 /PRNewswire/ -- OhioHealth Riverside Methodist Hospital is now treating patients with peripheral artery disease (PAD) with the first drug-eluting stent to be used outside of the heart. Cook Medical's Zilver PTX is a drug-coated stent that is used to reopen a long thigh artery, located above the knee (the femoropopliteal artery), narrowed or blocked due...
-- Coronary or Peripheral Artery Disease patients carry significant risk of fatal or debilitating myocardial infarction and stroke -- Rivaroxaban is the first novel oral anticoagulant currently under investigation in this high risk patient population -- 20,000-patient study will be conducted in collaboration with Canada's Population Health Research Institute (PHRI), representing one of the largest...
Connie K. Ho for redOrbit.com – Your Universe Online 20,000,000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy with intramuscular delivery. To begin, Pluristem uses stem cells from the human placenta and has created a manufacturing process that produces enough cells to treat 10,000 patients from one...
Peripheral artery disease, which covers problems in the arteries supplying the legs, arms and most organs, is often overlooked or misdiagnosed in women. Harvard Women's Health Watch offers tips for identifying and treating this all-too-common and potentially debilitating condition. Boston, MA (PRWEB) April 13, 2012 If ever a disease deserved a new name, peripheral artery disease is it. "Peripheral" smacks of something on the sidelines. Nothing could be further from the truth....
VIENNA, Va., March 12, 2012 /PRNewswire-USNewswire/ -- Affecting approximately 8 million Americans, peripheral artery disease (PAD) can lead to heart attack, stroke, amputation and death. PAD occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with PAD can be a red flag that other arteries,...
-- From Research at The Children's Hospital of Philadelphia, an Innovative Tool May Treat Peripheral Artery Disease -- PHILADELPHIA, March 1, 2012 /PRNewswire-USNewswire/ -- Vascular Magnetics, the first start-up company spun off by The Children's Hospital of Philadelphia, has raised $7 million to advance development of an innovative drug delivery system using magnetically targeted nanoparticles to treat peripheral artery disease. Vascular Magnetics, based in West Philadelphia,...
Women with peripheral artery disease, or PAD, are two to three times more likely to have a stroke or heart attack than those without it ― yet it's often unrecognized and untreated, especially in women, according to a new American Heart Association scientific statement. The statement is published in Circulation: Journal of the American Heart Association. The American Heart Association, in collaboration with the Vascular Disease Foundation and its Peripheral Artery Disease Coalition,...
ABBOTT PARK, Ill., Dec. 22, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the safety and performance of the novel Esprit((TM)) drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the superficial femoral arteries (SFA) and iliac arteries that have resulted in claudication (leg pain upon walking). Claudication is the most common symptom in...
Findings of CLEVER trial for peripheral artery disease presented at American Heart Association annual meeting Supervised exercise was shown to be more effective than stenting or medication for improved walking ability in patients with peripheral artery disease. The findings from a national study were reported today at the 2011 American Heart Association Scientific Sessions meeting. Rhode Island Hospital is one of hospitals participating in the national CLEVER study. Peripheral artery...
AUSTIN, Texas, Nov. 3, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has received a notice of allowance from the United States Patent and Trademark Office for its fifth patent covering a combination of biomarkers that could be used in the diagnosis of Peripheral Artery Disease (PAD), a condition that raises the risk of heart attack and stroke. The patent, entitled "Beta-2 Microglobulin (B2m) and C Reactive Protein (CRP) as Biomarkers for...
